Cargando…
(64)Cu-ATSM/(64)Cu-Cl(2) and their relationship to hypoxia in glioblastoma: a preclinical study
BACKGROUND: Diacetyl-bis(N4-methylthiosemicarbazone), labeled with 64Cu ((64)Cu-ATSM) has been suggested as a promising tracer for imaging hypoxia. However, various controversial studies highlighted potential pitfalls that may disable its use as a selective hypoxic marker. They also highlighted that...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6923301/ https://www.ncbi.nlm.nih.gov/pubmed/31858290 http://dx.doi.org/10.1186/s13550-019-0586-6 |
_version_ | 1783481504161071104 |
---|---|
author | Pérès, Elodie A. Toutain, Jérôme Paty, Louis-Paul Divoux, Didier Ibazizène, Méziane Guillouet, Stéphane Barré, Louisa Vidal, Aurélien Cherel, Michel Bourgeois, Mickaël Bernaudin, Myriam Valable, Samuel |
author_facet | Pérès, Elodie A. Toutain, Jérôme Paty, Louis-Paul Divoux, Didier Ibazizène, Méziane Guillouet, Stéphane Barré, Louisa Vidal, Aurélien Cherel, Michel Bourgeois, Mickaël Bernaudin, Myriam Valable, Samuel |
author_sort | Pérès, Elodie A. |
collection | PubMed |
description | BACKGROUND: Diacetyl-bis(N4-methylthiosemicarbazone), labeled with 64Cu ((64)Cu-ATSM) has been suggested as a promising tracer for imaging hypoxia. However, various controversial studies highlighted potential pitfalls that may disable its use as a selective hypoxic marker. They also highlighted that the results may be tumor location dependent. Here, we first analyzed uptake of Cu-ATSM and its less lipophilic counterpart Cu-Cl(2) in the tumor over time in an orthotopic glioblastoma model. An in vitro study was also conducted to investigate the hypoxia-dependent copper uptake in tumor cells. We then further performed a comprehensive ex vivo study to compare (64)Cu uptake to hypoxic markers, specific cellular reactions, and also transporter expression. METHODS: μPET was performed 14 days ((18)F-FMISO), 15 days ((64)Cu-ATSM and (64)Cu-Cl2), and 16 days ((64)Cu-ATSM and (64)Cu-Cl(2)) after C6 cell inoculation. Thereafter, the brains were withdrawn for further autoradiography and immunohistochemistry. C6 cells were also grown in hypoxic workstation to analyze cellular uptake of Cu complexes in different oxygen levels. RESULTS: In vivo results showed that Cu-ASTM and Cu-Cl2 accumulated in hypoxic areas of the tumors. Cu-ATSM also stained, to a lesser extent, non-hypoxic regions, such as regions of astrogliosis, with high expression of copper transporters and in particular DMT-1 and CTR1, and also characterized by the expression of elevated astrogliosis. In vitro results show that 64Cu-ATSM showed an increase in the uptake only in severe hypoxia at 0.5 and 0.2% of oxygen while for (64)Cu-Cl2, the cell retention was significantly increased at 5% and 1% of oxygen with no significant rise at lower oxygen percentages. CONCLUSION: In the present study, we show that Cu-complexes undoubtedly accumulate in hypoxic areas of the tumors. This uptake may be the reflection of a direct dependency to a redox metabolism and also a reflection of hypoxic-induced overexpression of transporters. We also show that Cu-ATSM also stained non-hypoxic regions such as astrogliosis. |
format | Online Article Text |
id | pubmed-6923301 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-69233012020-01-02 (64)Cu-ATSM/(64)Cu-Cl(2) and their relationship to hypoxia in glioblastoma: a preclinical study Pérès, Elodie A. Toutain, Jérôme Paty, Louis-Paul Divoux, Didier Ibazizène, Méziane Guillouet, Stéphane Barré, Louisa Vidal, Aurélien Cherel, Michel Bourgeois, Mickaël Bernaudin, Myriam Valable, Samuel EJNMMI Res Original Research BACKGROUND: Diacetyl-bis(N4-methylthiosemicarbazone), labeled with 64Cu ((64)Cu-ATSM) has been suggested as a promising tracer for imaging hypoxia. However, various controversial studies highlighted potential pitfalls that may disable its use as a selective hypoxic marker. They also highlighted that the results may be tumor location dependent. Here, we first analyzed uptake of Cu-ATSM and its less lipophilic counterpart Cu-Cl(2) in the tumor over time in an orthotopic glioblastoma model. An in vitro study was also conducted to investigate the hypoxia-dependent copper uptake in tumor cells. We then further performed a comprehensive ex vivo study to compare (64)Cu uptake to hypoxic markers, specific cellular reactions, and also transporter expression. METHODS: μPET was performed 14 days ((18)F-FMISO), 15 days ((64)Cu-ATSM and (64)Cu-Cl2), and 16 days ((64)Cu-ATSM and (64)Cu-Cl(2)) after C6 cell inoculation. Thereafter, the brains were withdrawn for further autoradiography and immunohistochemistry. C6 cells were also grown in hypoxic workstation to analyze cellular uptake of Cu complexes in different oxygen levels. RESULTS: In vivo results showed that Cu-ASTM and Cu-Cl2 accumulated in hypoxic areas of the tumors. Cu-ATSM also stained, to a lesser extent, non-hypoxic regions, such as regions of astrogliosis, with high expression of copper transporters and in particular DMT-1 and CTR1, and also characterized by the expression of elevated astrogliosis. In vitro results show that 64Cu-ATSM showed an increase in the uptake only in severe hypoxia at 0.5 and 0.2% of oxygen while for (64)Cu-Cl2, the cell retention was significantly increased at 5% and 1% of oxygen with no significant rise at lower oxygen percentages. CONCLUSION: In the present study, we show that Cu-complexes undoubtedly accumulate in hypoxic areas of the tumors. This uptake may be the reflection of a direct dependency to a redox metabolism and also a reflection of hypoxic-induced overexpression of transporters. We also show that Cu-ATSM also stained non-hypoxic regions such as astrogliosis. Springer Berlin Heidelberg 2019-12-19 /pmc/articles/PMC6923301/ /pubmed/31858290 http://dx.doi.org/10.1186/s13550-019-0586-6 Text en © The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Original Research Pérès, Elodie A. Toutain, Jérôme Paty, Louis-Paul Divoux, Didier Ibazizène, Méziane Guillouet, Stéphane Barré, Louisa Vidal, Aurélien Cherel, Michel Bourgeois, Mickaël Bernaudin, Myriam Valable, Samuel (64)Cu-ATSM/(64)Cu-Cl(2) and their relationship to hypoxia in glioblastoma: a preclinical study |
title | (64)Cu-ATSM/(64)Cu-Cl(2) and their relationship to hypoxia in glioblastoma: a preclinical study |
title_full | (64)Cu-ATSM/(64)Cu-Cl(2) and their relationship to hypoxia in glioblastoma: a preclinical study |
title_fullStr | (64)Cu-ATSM/(64)Cu-Cl(2) and their relationship to hypoxia in glioblastoma: a preclinical study |
title_full_unstemmed | (64)Cu-ATSM/(64)Cu-Cl(2) and their relationship to hypoxia in glioblastoma: a preclinical study |
title_short | (64)Cu-ATSM/(64)Cu-Cl(2) and their relationship to hypoxia in glioblastoma: a preclinical study |
title_sort | (64)cu-atsm/(64)cu-cl(2) and their relationship to hypoxia in glioblastoma: a preclinical study |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6923301/ https://www.ncbi.nlm.nih.gov/pubmed/31858290 http://dx.doi.org/10.1186/s13550-019-0586-6 |
work_keys_str_mv | AT pereselodiea 64cuatsm64cucl2andtheirrelationshiptohypoxiainglioblastomaapreclinicalstudy AT toutainjerome 64cuatsm64cucl2andtheirrelationshiptohypoxiainglioblastomaapreclinicalstudy AT patylouispaul 64cuatsm64cucl2andtheirrelationshiptohypoxiainglioblastomaapreclinicalstudy AT divouxdidier 64cuatsm64cucl2andtheirrelationshiptohypoxiainglioblastomaapreclinicalstudy AT ibazizenemeziane 64cuatsm64cucl2andtheirrelationshiptohypoxiainglioblastomaapreclinicalstudy AT guillouetstephane 64cuatsm64cucl2andtheirrelationshiptohypoxiainglioblastomaapreclinicalstudy AT barrelouisa 64cuatsm64cucl2andtheirrelationshiptohypoxiainglioblastomaapreclinicalstudy AT vidalaurelien 64cuatsm64cucl2andtheirrelationshiptohypoxiainglioblastomaapreclinicalstudy AT cherelmichel 64cuatsm64cucl2andtheirrelationshiptohypoxiainglioblastomaapreclinicalstudy AT bourgeoismickael 64cuatsm64cucl2andtheirrelationshiptohypoxiainglioblastomaapreclinicalstudy AT bernaudinmyriam 64cuatsm64cucl2andtheirrelationshiptohypoxiainglioblastomaapreclinicalstudy AT valablesamuel 64cuatsm64cucl2andtheirrelationshiptohypoxiainglioblastomaapreclinicalstudy |